Marshall Wace Portfolio holdings
AUM
$84.1B
This Quarter Return
+0.63%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$20.2B
AUM Growth
+$20.2B
(+6.5%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
7.36%
Top 10 Holdings %
Top 10 Hldgs %
12.05%
Holding
3,463
New
958
Increased
738
Reduced
563
Closed
667
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$137M |
| 2 |
Uber
UBER
|
$130M |
| 3 |
Canadian Pacific Kansas City
CP
|
$112M |
| 4 |
The Beauty Health Co
SKIN
|
$107M |
| 5 |
Dynavax Technologies
DVAX
|
$98.3M |
Top Sells
| 1 |
PARA
Paramount Global Class B
PARA
|
$181M |
| 2 |
Biogen
BIIB
|
$181M |
| 3 |
Danaher
DHR
|
$108M |
| 4 |
XYZ
Block, Inc.
XYZ
|
$103M |
| 5 |
Aon
AON
|
$100M |
Sector Composition
| 1 | Healthcare | 24.21% |
| 2 | Financials | 19.75% |
| 3 | Technology | 16.44% |
| 4 | Consumer Discretionary | 13.14% |
| 5 | Industrials | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Five Below
FIVE
$8.33B
| $28.7M | 0.12% |
162,541
+156,945
| +2,805% | +$27.7M |
|
152
Meta Platforms (Facebook)
META
$1.85T
| $28.7M | 0.12% |
84,629
-121,090
| -59% | -$41.1M |
|
153
CRISPR Therapeutics
CRSP
$4.82B
| $28.6M | 0.12% |
+255,727
| New | +$28.6M |
|
154
BCE
BCE
$22.9B
| $28.1M | 0.12% |
560,900
-360,938
| -39% | -$18.1M |
|
155
Salesforce
CRM
$245B
| $27.7M | 0.12% |
102,271
-361,937
| -78% | -$98.2M |
|
156
Lamb Weston
LW
$7.88B
| $27.4M | 0.11% |
445,989
+410,263
| +1,148% | +$25.2M |
|
157
Energy Select Sector SPDR Fund
XLE
$27.1B
| $27.3M | 0.11% |
523,809
+400,062
| +323% | +$20.8M |
|
158
Adobe
ADBE
$148B
| $27.2M | 0.11% |
47,164
+38,359
| +436% | +$22.1M |
|
159
Deutsche Bank
DB
$67B
| $27M | 0.11% |
2,114,517
+1,613,144
| +322% | +$20.6M |
|
160
Canadian Imperial Bank of Commerce
CM
$72.9B
| $27M | 0.11% |
485,240
+106,306
| +28% | +$5.92M |
|
|
CVII
161
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $26.9M | 0.11% |
2,767,338
+1,821,033
| +192% | +$17.7M |
|
162
Denali Therapeutics
DNLI
$2.24B
| $26.8M | 0.11% |
531,358
-114,641
| -18% | -$5.78M |
|
|
CD
163
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $26.7M | 0.11% |
3,177,564
+2,403,120
| +310% | +$20.2M |
|
164
Palo Alto Networks
PANW
$128B
| $26.7M | 0.11% |
334,596
+321,420
| +2,439% | +$25.7M |
|
165
Applovin
APP
$165B
| $26.6M | 0.11% |
+367,110
| New | +$26.6M |
|
166
Bank of America
BAC
$371B
| $26.4M | 0.11% |
621,096
+553,845
| +824% | +$23.5M |
|
167
Zai Lab
ZLAB
$3.48B
| $26.3M | 0.11% |
249,681
+246,076
| +6,826% | +$25.9M |
|
168
InMode
INMD
$917M
| $26.2M | 0.11% |
328,852
+227,690
| +225% | +$18.2M |
|
169
Gen Digital
GEN
$18.3B
| $26.2M | 0.11% |
1,033,586
+911,483
| +746% | +$23.1M |
|
170
BioMarin Pharmaceuticals
BMRN
$11.3B
| $26M | 0.11% |
335,985
+295,034
| +720% | +$22.8M |
|
171
Allegion
ALLE
$14.4B
| $25.7M | 0.11% |
194,591
+84,668
| +77% | +$11.2M |
|
|
GOAC
172
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
| $25.7M | 0.11% |
2,620,325
+660,343
| +34% | +$6.48M |
|
173
RH
RH
$4.14B
| $25.5M | 0.11% |
38,299
-13,332
| -26% | -$8.89M |
|
|
DQ
174
Daqo New Energy
DQ
$1.78B
| $25.3M | 0.11% |
+444,470
| New | +$25.3M |
|
175
McDonald's
MCD
$226B
| $25.1M | 0.1% |
104,296
-32,208
| -24% | -$7.77M |
|